Insulin pump
Insulin pump is a medical device with 27 clinical trials. Currently 1 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
6
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
63.2%
12 of 19 finished
36.8%
7 ended early
1
trials recruiting
27
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pilot Study of Intrapartum Insulin Pump
Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
Hybrid Closed-loop Insulin Delivery System in Perioperative Diabetic Patients: an Open-label, Randomized Controlled Trial
Automated Insulin Delivery vs. Injections: Sleep Impact in Pediatric Type 1 Diabetes
Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel.
Clinical Trials (27)
Pilot Study of Intrapartum Insulin Pump
Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes
Hybrid Closed-loop Insulin Delivery System in Perioperative Diabetic Patients: an Open-label, Randomized Controlled Trial
Automated Insulin Delivery vs. Injections: Sleep Impact in Pediatric Type 1 Diabetes
Insulin Pump-RT Advisor (IPRA©): a Decision Support Software for Diabetic Patients Treated by Insulin Pump and Using Continuous Glucose Monitoring. Experimental Study. Evaluation by an Expert Patient Panel.
The SMART B Exercise Study :''The SMART Study''
Clinical Efficacy of Insulin Pumps in Type 1 Diabetes Mellitus Patients in Spain
Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels
Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes
Faster Aspart on Insulin-pump Treated T1DM Patients
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes
Evaluation of iDECIDE: A Smartphone App for Insulin Dosing Accounting for Alcohol and Exercise
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes
Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes
Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes
Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.
Insulin-based Strategies to Prevent Hypoglycemia During Exercise
Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels
Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 27